Katie Hobbins

A look at what the Contemporary Pediatrics® team covered this week.

Recently, the FDA announced the approval of supplemental indication for phentermine and topiramate extended-release capsules for chronic weight management in children aged 12 years and older.

The AAP recently updated their recommendations urging schools to be prepared for emergency medical situations including seizures, diabetes, allergies/anaphylaxis, mental health, substance use, or asthma.

A look at what the Contemporary Pediatrics® team covered this week.

The annual WLSL event brings together hundreds of swim instructors across to world to hold life-saving swim lessons in the hopes of preventing childhood drowning.

Recently, the AAP announced the launch of a public health campaign to educate caregivers on the benefits of vaccinating all ages.

The FDA today approved the pneumococcal 15-valent conjugate vaccine for the prevention of invasive pneumococcal disease in infants and children.

This week, the American Academy of Pediatrics updated their safe sleep recommendations and released the 2022 bright futures/AAP periodicity schedule for preventive pediatric health care. In part 1, we focus on the updates in sleep recommendations.

Data from Morbidity and Mortality Weekly Report showed that there was no demonstrated increase in pediatric hepatitis or adenovirus 40/41 above pre-COVID-19 pandemic baseline levels.

In a video for Contemporary Pediatrics®, Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, discusses how the Ann & Robert H. Lurie Children’s Hospital of Chicago, Illinois, caters to their pediatric patients in an effort to keep them de-stressed and comfortable.

A look at what the Contemporary Pediatrics® team covered this week.

The FDA today announces the EUA of both Moderna and Pfizer-BioNTech COVID-19 vaccines for use in children aged 6 months and older.

The United States Food and Drug Administration (FDA) has approved the import of over 66 million servings of infant formula from Singapore, focusing on supply for vulnerable consumers.

The US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee unanimously voted recently to recommend both the Pfizer-BioNTech and Moderna COVID-19 vaccines for individuals aged 6 months and older.

Ahead of the US Senate Judiciary Committee hearing on gun violence prevention, the American Academy of Pediatrics announced the submission of a statement including more than 300 pediatricians sharing their personal testimonies on the subject.

Data from a recent study of once weekly somapacitan injection shows positive results for prepubertal children with growth hormone deficiency (GHD).

A new study examined the effectiveness of different survey recruitment strategies when engaging parents of children with autism.

The FDA recently announced the acceptance of a supplemental New Drug Application for relugolix 40 mg, estradiol 1 mg, and norethindrone acetate .5 mg in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

A look at what the Contemporary Pediatrics® team covered this week.

The FDA recently announced an e-cigarette prevention campaign aimed at Native American and Alaskan Native youth using prominent social media sites and traditional media like billboards, radio, and TV.

In a video for Contemporary Pediatrics®, Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses an expansion of vaccine access likely to come with the FDA approval of the PRIORIX vaccine.

April Armstrong, MD, MPH, highlights her recommendations for improving patients’ outcomes, engagement, and satisfaction as part of a panel presentation at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

GSK plc today announced FDA approval of the PRIORIX vaccine for prevention of measles, mumps, and rubella.

A poster presented at the 2022 Fall Clinical Dermatology Conference for PAs & NPs showed normalization of skin barrier function in patients with moderate to severe atopic dermatitis taking dupilumab, according to the investigators.

Setting reasonable expectations before pediatric cochlear implant surgery remains an important step in the consultation process.

In a video, John Oghalai, MD, discusses co-authoring a recent study on cochlear implant efficacy in children experiencing deafness and developmental delays.

A look at what the Contemporary Pediatrics® team covered this week.

A new study examines the relationship between an extended duration of mother-child breastfeeding and protective associations to asthma.

Donna Hallas, a Contemporary Pediatrics® Editorial Advisory Board member, discusses the infant formula shortage.

A recent study highlighted results showing an almost 25% improvement in cognition, adaptive behavior, language, and auditory skills in children with developmental delays when using a cochlear implant compared to hearing aids.